(Tilray, Inc.)

	TLRY latest price $90.6800 (-16.1%) ($88.0800 - $114.0000) on Mon. Oct. 29, 2018.
	Trend Analysis and Forecast
Average Daily Percentage Swing	12.03% (three month average)
RSI	38
Latest Price	$90.6800(-16.1%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	TLRY declines -5.6% a day on average for past five trading days.
Weekly Trend	TLRY declines -13.2% a week on average for past two weeks.
Market Behavior	Rotation from growth to value for large cap. Growth stock sell-off for small cap.
Correlated ETFs	Broad market will support TLRY advance at 0% a week (0% probability)   IYT(14%)    XLC(12%)    IBB(9%)    OIH(9%)    PAVE(9%)
Factors Impacting TLRY price	TLRY will decline at least -6.015% in a week (0% probabilities).   SLV(-10%)    GLD(-7%)    XHB(-6%)    SHY(-6%)    IFRA(-6%)
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-6.015% (StdDev 12.03%)
Hourly BBV	0 ()
Intraday Trend	-20.3%

Resistance Level	$134.28
5 Day Moving Average	$107.12(-15.35%)
10 Day Moving Average	$124.91(-27.4%)
20 Day Moving Average	$134.28(-32.47%)
To recent high	-57.6%
To recent low	310.3%
Market Cap	$11.419b

Tilray, Inc. engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids. The Company is focused on medical cannabis research, cultivation, processing and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It also supplies cannabis products to patients in a number of countries spanning five continents through its subsidiaries in Australia, Canada and Germany and it produces medical cannabis in Canada and Europe. The company was founded on January 24, 2018 and is headquartered in Nanaimo, Canada.

getNextHourMoveProbability failed